Rhinocerebral zygomycosis.
An unusual case of rhinocerebral zygomycosis with its clinical and histopathological features are presented. A good response was observed with oral itraconazole at a dose of 200 mg day-1 for a period of 3 months. To our knowledge, it is the first case report of this infection, involving the maxillary sinus, eye and the brain, from Madras, Tamilnadu, India.
Parthiban
K
K
Department of Dermatology, Madras Medical College, India.
Gnanaguruvelan
S
S
Janaki
C
C
Sentamilselvi
G
G
Boopalraj
J M
JM
D000935:Antifungal Agents / Q000627:therapeutic use; D001927:Brain Diseases / Q000150:complications* / Q000188:drug therapy; D048909:Diabetes Complications; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000150:complications* / Q000188:drug therapy; D009886:Ophthalmoplegia / Q000188:drug therapy / Q000209:etiology; D009894:Opportunistic Infections / Q000150:complications* / Q000188:drug therapy; D010254:Paranasal Sinus Diseases / Q000150:complications* / Q000188:drug therapy
D000935:Antifungal Agents; D017964:Itraconazole